CORDLESS- Collagenase Optimal Reduction of Dupuytren's - Long-term Evaluation of Success Study
CORDLESS- Collagenase Optimal Reduction of Dupuytren's - Long-term Evaluation of Success Study
The purpose of study AUX-CC-860 is to assess the durability of response of the AA4500 treatment regimen. This study will also evaluate long-term safety and progression of disease in joints.
Phase 3 non-treatment study in which Year 2 to Year 5 year follow-up of subjects who received AA4500 in the 9-month open-label studies (AUX-CC-854 and AUX-CC-856) or the 12-month double-blind with open-label extension studies (AUX-CC-857/AUX-CC-858 and AUX-CC-859). After completion of one of the above mentioned studies, subjects are enrolled and followed once a calendar year for 4 consecutive years with at least 6 months between consecutive visits.
Inclusion Criteria:
To be eligible for this study a subject had to:
Exclusion Criteria:
Boston, Massachusetts 02115, United States
Newcastle, Newcastle Upon Tyne NE1 4LP, United Kingdom